Sandip Tiwari's Biography

Sandip Tiwari, Technical Director, Colorcon Asia Private Limited

Dr. Sandip B. Tiwari is currently Technical Director-South Asia, Colorcon Asia Pvt. Ltd, Goa, India. In his current role, Dr. Tiwari is responsible for the technical activities of the company in South Asia region. He is also responsible for leading the Formulation Center of Excellence, FCE (product development laboratory) in Goa. Prior to his relocation to India in July 2011, Sandip was a Senior Manager, Product Development at Colorcon Inc., Harleysville, PA, USA for over 5 years, where he was responsible for the development of the extended release matrix system portfolio including design and development of osmotic drug delivery technology platform, implementation of Quality by Design (QbD) initiatives for extended release hydrophilic matrix systems and developing strategies for modulation of drug release profiles from hydrophilic matrices.
Dr. Tiwari was also a post-doctoral fellow at Northeastern University, Boston, MA, USA where he investigated the application of nanotechnology in drug delivery and diagnostics. While in India, Dr. Tiwari worked at the Zydus Research Center, Ahmedabad, India, as an Associate Research Scientist and then as a Senior Scientist and Head of the Department of Novel Drug Delivery Systems. He led a team that developed the formulation for NCE for “first dose” in humans that subsequently completed Phase III trials and approved for commercialization in India under the name of Lipaglyn™ : the world’s first drug for treating diabetic dyslipidemia (Saroglitazar). He was also instrumental in developing several formulations that were subsequently approved by USFDA as ANDAs. He has over 15 years’ experience in the pharmaceutical field and has participated in various stages of drug development during his career. He earned his PhD in Pharmaceutical Sciences from College of Pharmaceutical Sciences, Manipal, Karnataka, India.
He has written six book chapters/ monographs and contributed more than 100 research publications and conference presentations in the areas of controlled release technology, non-invasive drug delivery, and nanotechnology. He has spoken at many national and international conferences as an invited speaker.